title: Case series: does a combination of anti-tnf antibodies and transient ileal fecal stream diversion in severe Crohn's colitis with perianal fistula prevent definitive stoma?
authors.affiliation: Service de Gastroentérologie, MICI et Assistance Nutritive, Hôpital Beaujon, Assistance Publique Hôpitaux de Paris, Clichy, France.
authors.forename: Mathieu
authors.initials: M
authors.lastname: Uzzan
authors.forename: Carmen
authors.initials: C
authors.lastname: Stefanescu
authors.forename: Léon
authors.initials: L
authors.lastname: Maggiori
authors.forename: Yves
authors.initials: Y
authors.lastname: Panis
authors.forename: Yoram
authors.initials: Y
authors.lastname: Bouhnik
authors.forename: Xavier
authors.initials: X
authors.lastname: Treton
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications / Q000628:therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007081:Ileostomy / Q000379:methods*; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012003:Rectal Fistula / Q000209:etiology / Q000628:therapy; D012006:Rectovaginal Fistula / Q000209:etiology / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab